Curis Inc (CRIS)
14.80
+0.03
(+0.20%)
USD |
NASDAQ |
Apr 25, 12:51
Curis Price: 14.80 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 15.01 | 15.07 | 14.54 | 14.77 | 4734.00 |
Apr 23, 2024 | 14.64 | 15.01 | 14.56 | 15.01 | 5785.00 |
Apr 22, 2024 | 14.27 | 14.85 | 14.06 | 14.85 | 21156.00 |
Apr 19, 2024 | 14.97 | 15.16 | 14.26 | 14.31 | 10228.00 |
Apr 18, 2024 | 16.50 | 16.50 | 14.63 | 15.22 | 19676.00 |
Apr 17, 2024 | 15.49 | 16.31 | 15.49 | 15.95 | 36504.00 |
Apr 16, 2024 | 14.81 | 15.27 | 14.11 | 15.27 | 22420.00 |
Apr 15, 2024 | 15.30 | 15.30 | 13.99 | 14.56 | 20198.00 |
Apr 12, 2024 | 15.91 | 16.24 | 14.92 | 15.28 | 8007.00 |
Apr 11, 2024 | 15.42 | 16.06 | 14.85 | 15.90 | 16147.00 |
Apr 10, 2024 | 15.35 | 15.35 | 15.00 | 15.28 | 13014.00 |
Apr 09, 2024 | 16.50 | 16.70 | 14.84 | 15.58 | 47618.00 |
Apr 08, 2024 | 17.49 | 17.49 | 16.01 | 16.50 | 40389.00 |
Apr 05, 2024 | 15.84 | 16.80 | 15.00 | 16.80 | 44960.00 |
Apr 04, 2024 | 13.41 | 17.49 | 13.41 | 16.01 | 314914.0 |
Apr 03, 2024 | 12.06 | 13.40 | 11.32 | 13.40 | 28132.00 |
Apr 02, 2024 | 12.70 | 12.70 | 11.95 | 12.32 | 37771.00 |
Apr 01, 2024 | 10.85 | 12.68 | 10.69 | 12.68 | 46284.00 |
Mar 28, 2024 | 10.95 | 10.95 | 10.41 | 10.87 | 23493.00 |
Mar 27, 2024 | 10.14 | 10.88 | 10.08 | 10.87 | 40199.00 |
Mar 26, 2024 | 10.83 | 10.83 | 10.02 | 10.09 | 24780.00 |
Mar 25, 2024 | 10.80 | 10.94 | 10.51 | 10.83 | 7421.00 |
Mar 22, 2024 | 11.00 | 11.07 | 10.42 | 10.80 | 16055.00 |
Mar 21, 2024 | 10.39 | 11.00 | 10.39 | 10.83 | 15201.00 |
Mar 20, 2024 | 10.20 | 10.33 | 10.03 | 10.33 | 16214.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.885
Minimum
Oct 25 2023
325.40
Maximum
May 12 2021
56.22
Average
24.10
Median
Price Benchmarks
Kura Oncology Inc | 18.72 |
AIM ImmunoTech Inc | 0.388 |
Perspective Therapeutics Inc | 1.595 |
Protalix BioTherapeutics Inc | 1.185 |
Armata Pharmaceuticals Inc | 2.59 |
Price Related Metrics
PS Ratio | 7.812 |
Price to Book Value | 4.435 |
Earnings Yield | -60.54% |
Market Cap | 87.23M |